Arrowhead Research | ARWR - Trade Creditors


Arrowhead Research reported $32.94M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xencor USD 10.83M 1.75M Dec/2025